|
|
Profiling ER, PR, EGFR and HER2 in Breast Cancer Using Multiplex Tissue Immusta
|
5R44CA123994-03
|
$106,461
|
$106,461
|
JAMES, WILLIAM
|
20/20 GENESYSTEMS, INC.
|
|
|
SBIR Topic 264 - (Phase 1) "Development of a Methylation Ratio Assessment Assay"
|
N43CO900048-000
|
$142,932
|
$142,932
|
Challis, Barton
|
ACTIVE MOTIF:1107110
|
|
|
Multiplex Gene Expression in Single Cells for Circulating Tumor Cell Detection
|
5R44CA122444-03
|
$547,101
|
$547,101
|
LUO, YULING
|
ADVANCED CELL DIAGNOSTICS, INC.
|
|
|
Antiangiogenic and antitumoral therapy delivered by a dual-expression L. monocyto
|
1R43CA137915-01A1
|
$210,739
|
$210,739
|
Wallecha, Anu
|
ADVAXIS, INC.
|
|
|
Pharmacology of Cyclophosphamide and Other Alkylators
|
7R01CA016783-34
|
$286,687
|
$143,344
|
LUDEMAN, SUSAN
|
ALBANY COLLEGE OF PHARMACY
|
|
|
Site-directed Chemotherapy for Breast Cancer using Novel Angiogenesis Inhibitor
|
1R21CA135245-01A1
|
$169,400
|
$169,400
|
MOUSA, SHAKER
|
ALBANY COLLEGE OF PHARMACY
|
|
|
Regulation of Fibronectin Matrix Assembly by uPAR
|
5R01CA058626-16
|
$281,080
|
$140,540
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
|
KLF8 Regulation of EMT Tumor Metastasis
|
1R01CA132977-01A2
|
$290,359
|
$290,359
|
ZHAO, JIHE
|
ALBANY MEDICAL COLLEGE
|
|
|
Old Drugs and New Strategies for Tumor Metastasis
|
5R01CA129598-02
|
$249,000
|
$249,000
|
BRESNICK, ANNE
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
MOTILITY AND INVASION
|
5P01CA100324-07
|
$2,056,747
|
$2,056,747
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
MICROENVIRONMENTS OF INVASION IN HUMAN BREAST TUMORS
|
5R01CA113395-04
|
$286,106
|
$286,106
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Novel Methods for Detecting Cell Interactions in the Tumor Microenvironment
|
5U54CA126511-04
|
$548,821
|
$548,821
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
5P30CA013330-37
|
$3,927,232
|
$903,263
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
New Approaches to Prevent or Treat Breast Cancer Metastases
|
5R21CA129470-03
|
$186,750
|
$186,750
|
GRAVEKAMP, CLAUDIA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
EMT, Extravasation and metastasis by N-Cadherin signaling
|
1R01CA135061-01A1
|
$344,450
|
$344,450
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
R-Cadherin in Breast Cancer Suppression
|
1R01CA136854-01A1
|
$344,450
|
$344,450
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
H/D Exchange Coupled to MS to Study Drug-Induced Change in Microtuble Structure
|
5R01CA124898-03
|
$315,400
|
$157,700
|
HORWITZ, SUSAN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Macrophages and Tumor Angiogenesis
|
5R01CA131270-02
|
$344,350
|
$344,350
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS
|
5R01CA077522-08
|
$292,658
|
$292,658
|
SEGALL, JEFFREY
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Glycosylation Mutants of Mice and Animal Cells
|
5R01CA030645-28
|
$520,266
|
$171,688
|
STANLEY, PAMELA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
"Alpha Particle-emitting Erb-2 Tumor-targeting Peptides" - Topic 255
|
N43CO900062-000
|
$150,000
|
$75,000
|
Testa, Richard
|
ALPHAMED INC:1120333
|
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
5U01CA098710-06
|
$550,218
|
$275,109
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S1
|
$26,578
|
$3,721
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-22
|
$1,683,081
|
$235,631
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$1,112,049
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
|
5R01CA065435-11
|
$564,543
|
$112,909
|
WILSON, JESSE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Recovery of Proteins from Formalin-fixed Tissues under High Hydrostatic Pressure
|
1R21CA134359-01A1
|
$144,650
|
$47,735
|
FOWLER, CAROL
|
AMERICAN REGISTRY OF PATHOLOGY, INC.
|
|
|
Inhibitors of p90Rsk
|
5R01CA116566-04
|
$182,407
|
$182,407
|
Hecht, Sidney
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Biomarker Detection Using NAPPA Tumor Antigen Arrays
|
7U01CA117374-05
|
$440,121
|
$220,061
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Molecular Target Focused Discovery of Anticancer Drugs
|
5R01CA090441-07
|
$381,250
|
$53,375
|
PETTIT, GEORGE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins
|
5R01CA125063-03
|
$380,792
|
$380,792
|
PETRENKO, VALERY
|
AUBURN UNIVERSITY AT AUBURN
|
|
|
High-Throughput Evaluation of Breast Cancer Markers
|
5U01CA117378-05
|
$406,135
|
$406,135
|
ZANGAR, RICHARD
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$182,420
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
|
Targeting AP-1 / ER Crosstalk for the Prevention and Treatment of Breast Cancer
|
5R01CA123246-03
|
$285,000
|
$285,000
|
BROWN, POWEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
REGULATION OF GENETIC STABILITY BY THE INT6 FAMILY
|
5R01CA090464-07
|
$272,340
|
$272,340
|
CHANG, ERIC
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Breast cancer response markers to a dual HER1/2 blocker
|
5R01CA112305-05
|
$252,236
|
$252,236
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
NSABP Participating Sites
|
5U10CA118735-04
|
$67,765
|
$57,600
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
5R01CA072038-12
|
$300,198
|
$300,198
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Translational Breast Cancer Research Training Program
|
5T32CA090221-07
|
$263,406
|
$263,406
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Molecular Dissection of Tumor Invasion
|
5R01CA087751-08
|
$246,598
|
$123,299
|
GOODE, SCOTT
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Mechanisms of the Adenovirus E4-ORF1 Oncoprotein
|
2R01CA058541-15A1
|
$317,065
|
$317,065
|
Javier, Ronald
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Targeting the phosphoinositide kinase chain to prevent breast cancer metastasis
|
1R03CA139545-01
|
$76,750
|
$76,750
|
KUNZ, JEANNETTE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Regulation of Mammary Stem Cells
|
5R01CA127857-02
|
$318,513
|
$318,513
|
LEWIS, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
PROGENITOR CELLS AND ONCOGENE TARGETS IN BREAST CANCER
|
5R01CA113869-05
|
$280,899
|
$280,899
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
High Content Analysis to Identify Biomarkers for Chemopreventive Drug Activity
|
5R03CA137777-02
|
$76,750
|
$76,750
|
MANCINI, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Multiplexed Methods for the Study of Chromosomal Aberrations in Cancer
|
5R33CA114151-03
|
$229,843
|
$229,843
|
MILOSAVLJEVIC, ALEKSANDAR
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S1
|
$117,279
|
$42,220
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S2
|
$245,600
|
$88,416
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-03
|
$1,515,000
|
$545,400
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Translational Research in Breast Cancer
|
5P50CA058183-15
|
$2,300,000
|
$2,300,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Total relevant funding to Breast for this search: $599,519,190
|
